These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 18271941)
21. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. Jang SH; Wientjes MG; Au JL J Pharmacol Exp Ther; 2001 Mar; 296(3):1035-42. PubMed ID: 11181938 [TBL] [Abstract][Full Text] [Related]
22. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts. Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960 [TBL] [Abstract][Full Text] [Related]
23. Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging. Morosi L; Spinelli P; Zucchetti M; Pretto F; Carrà A; D'Incalci M; Giavazzi R; Davoli E PLoS One; 2013; 8(8):e72532. PubMed ID: 23991120 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Luo Y; Prestwich GD Bioconjug Chem; 1999; 10(5):755-63. PubMed ID: 10502340 [TBL] [Abstract][Full Text] [Related]
26. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Xie J; Wang CH Pharm Res; 2005 Dec; 22(12):2079-90. PubMed ID: 16132339 [TBL] [Abstract][Full Text] [Related]
27. Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model. Gupta SK; Torrico Guzmán EA; Meenach SA Int J Cancer; 2017 Nov; 141(10):2143-2153. PubMed ID: 28771722 [TBL] [Abstract][Full Text] [Related]
28. Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel. Lee SJ; Kim SW; Chung H; Park YT; Choi YW; Cho YH; Yoon MS Chemotherapy; 2005 Oct; 51(6):311-8. PubMed ID: 16224181 [TBL] [Abstract][Full Text] [Related]
29. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity. Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208 [TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763. Miller AA; Rosner GL; Egorin MJ; Hollis D; Lichtman SM; Ratain MJ Clin Cancer Res; 2004 Dec; 10(24):8325-31. PubMed ID: 15623609 [TBL] [Abstract][Full Text] [Related]
31. Superior intratumoral penetration of paclitaxel nanodots strengthens tumor restriction and metastasis prevention. Ni D; Ding H; Liu S; Yue H; Bao Y; Wang Z; Su Z; Wei W; Ma G Small; 2015 Jun; 11(21):2518-26. PubMed ID: 25678130 [TBL] [Abstract][Full Text] [Related]
32. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment. Knemeyer I; Wientjes MG; Au JL Cancer Chemother Pharmacol; 1999; 44(3):241-8. PubMed ID: 10453726 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys. Xu L; Zuch CL; Lin YS; Modi NB; Lum BL Cancer Chemother Pharmacol; 2008 Apr; 61(4):607-14. PubMed ID: 17549476 [TBL] [Abstract][Full Text] [Related]
34. Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Kyle AH; Huxham LA; Yeoman DM; Minchinton AI Clin Cancer Res; 2007 May; 13(9):2804-10. PubMed ID: 17473214 [TBL] [Abstract][Full Text] [Related]
35. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Wang C; Ho PC; Lim LY Int J Pharm; 2010 Nov; 400(1-2):201-10. PubMed ID: 20804835 [TBL] [Abstract][Full Text] [Related]
36. Nab-paclitaxel is an active drug in preclinical model of pediatric solid tumors. Zhang L; Marrano P; Kumar S; Leadley M; Elias E; Thorner P; Baruchel S Clin Cancer Res; 2013 Nov; 19(21):5972-83. PubMed ID: 23989978 [TBL] [Abstract][Full Text] [Related]
37. Paclitaxel pharmacodynamics: application of a mechanism-based neutropenia model. Fetterly GJ; Tamburlin JM; Straubinger RM Biopharm Drug Dispos; 2001 Sep; 22(6):251-61. PubMed ID: 11754041 [TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Au JL; Li D; Gan Y; Gao X; Johnson AL; Johnston J; Millenbaugh NJ; Jang SH; Kuh HJ; Chen CT; Wientjes MG Cancer Res; 1998 May; 58(10):2141-8. PubMed ID: 9605758 [TBL] [Abstract][Full Text] [Related]
39. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice. Dalela M; Shrivastav TG; Kharbanda S; Singh H ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585 [TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. Ceruti M; Crosasso P; Brusa P; Arpicco S; Dosio F; Cattel L J Control Release; 2000 Jan; 63(1-2):141-53. PubMed ID: 10640588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]